The Affiliated Hospital of Qingdao University Branch North

Qingdao, Shandong 266000

1 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumor

Studies at this site

• A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors — Recruiting now